New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
10:00 EDTMDVN, FUR, AEGR, RPTP, SWKS, QSII, GWAY, WGP, LLNW, CERN, STAG, IDRA, AKAMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Akamai (AKAM) initiated with a Neutral at Macquarie... Cerner (CERN) initiated with an Overweight at JPMorgan... Greenway Medical (GWAY) initiated with an Overweight at JPMorgan... Idera Pharmaceuticals (IDRA) initiated with an Overweight at Piper Jaffray... Limelight Networks (LLNW) initiated with a Neutral at Macquarie... Quality Systems (QSII) initiated with an Underweight at JPMorgan... STAG Industrial (STAG) initiated with a Market Perform at Wells Fargo... Western Gas Equity (WGP) initiated with a Buy at Citigroup... Winthrop Realty (FUR) initiated with a Market Perform at JMP Securities... Skyworks (SWKS) initiated with a Buy at Longbow... Aegerion (AEGR) initiated with a Buy at Janney Capital... Medivation (MDVN) initiated with a Buy at Janney Capital... Raptor Pharmaceuticals (RPTP) initiated with a Buy at Janney Capital.
News For AKAM;CERN;GWAY;IDRA;LLNW;QSII;STAG;WGP;FUR;SWKS;AEGR;MDVN;RPTP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 26, 2015
10:30 EDTSWKSSkyworks volatility elevated on share pullback
Subscribe for More Information
08:54 EDTSTAGSTAG Industrial management to meet with JMP Securities
Meeting to be held in St Louis on March 31 hosted by JMP Securities.
March 25, 2015
09:06 EDTMDVNMedivation price target raised to $144 from $123 at William Blair
Subscribe for More Information
08:06 EDTAKAMBioMed Realty leases Akamai 67L square feet in Cambridge Innovation District
Subscribe for More Information
07:53 EDTMDVNMedivation reported strong, positive results, says JMP Securities
JMP Securities says that the results of a study comparing Medivation's Xtandi to bicalutamide, the market leading prostate cancer medication, were strong and positive for Medivation. The firm continues to expect Xtandi to prove to be superior to bicalutamide. It expects Xtandi to generate $8B in worldwide revenue and raised its price target on Medivation to $143 from $126 while keeping an Outperform rating on the shares.
07:39 EDTMDVNMedivation price target raised to $142 from $125 at Brean Capital
Brean Capital raised its price target on Medivation to $142 from $125 following the presentation of additional Phase 2 TERRAIN trial data in metastatic castration-resistant prostate cancer and final OS data from the Phase 3 PREVAIL trial in chemo-naive mCRPC. The firm remains optimistic by consistent and positive data and reiterated its Buy rating on Medivation shares.
07:02 EDTMDVNMedivation price target raised to $148 from $130 at JPMorgan
Subscribe for More Information
06:40 EDTAKAMAkamai reports Q4 DDos attack traffic up 20% vs. Q3
Subscribe for More Information
March 24, 2015
10:15 EDTRPTPRaptor Pharmaceuticals management to meet with Leerink
Subscribe for More Information
07:07 EDTMDVNAstellas Pharma and Medivation report data from Phase 2 Terrain trial
Subscribe for More Information
March 23, 2015
09:27 EDTIDRAIdera Pharmaceuticals Chief Medical Officer resigns
Idera Pharmaceuticals disclosed in a regulatory filing that Louis Brenner, M.D. resigned his positions as senior VP and Chief Medical Officer of Idera to accept a new role as the Chief Operating Officer of a privately-held biotechnology company. This change will become effective April 3.
March 20, 2015
16:22 EDTQSIIQuality Systems CFO Paul Holt resigns, John Stumpf named as interim CFO
On March 18, Paul Holt informed the board the he will resign as CFO of the company, effective April 12. Holt has served the company for over 15 years and is leaving to join NantHealth as its CFO. On March 19, the board appointed John Stumpf as the company's interim CFO, effective immediately upon Holt's departure from the company.
08:17 EDTAKAMAkamai volatility low as shares near 14-year high
Subscribe for More Information
March 19, 2015
17:16 EDTLLNWLimelight appoints Michael DiSanto as Chief Administrative and Legal Officer
Subscribe for More Information
10:02 EDTQSIIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:02 EDTCERNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
March 18, 2015
16:07 EDTQSIIQuality Systems downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
16:06 EDTCERNCerner upgraded to Outperform from Neutral at RW Baird
Subscribe for More Information
11:25 EDTSWKSStocks with call strike movement; SWKS MU
Subscribe for More Information
09:33 EDTCERNCerner selected by Washington hospitals to update health record systems
The State of Washington Department of Social and Health Services has selected health IT supplier Cerner to modernize integrated revenue cycle and electronic health records in multiple state facilities to prepare for ICD-10 compliance. The agreement will digitize DSHS' paper health records. Cerner will implement Millennium PowerChart and the revenue cycle suite of solutions at three accredited psychiatric hospitals, including Western State Hospital, Eastern State Hospital and Child Studies and Treatment Center. Cerner will replace the billing functionality supported by the Residential Programs System, as well as the central pharmacy system. DSHS' system will be hosted at Cerner's Kansas City data center.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use